↓ Skip to main content

Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women

Overview of attention for article published in Cochrane database of systematic reviews, September 2010
Altmetric Badge

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
123 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women
Published in
Cochrane database of systematic reviews, September 2010
DOI 10.1002/14651858.cd007063.pub2
Pubmed ID
Authors

Sharif I Ismail, Christine Bain, Suzanne Hagen

Abstract

Pelvic organ prolapse is common and can be detected in up to 50% of parous women although many are asymptomatic. Oestrogen preparations are used to improve vaginal thinning (atrophy). It is possible that oestrogens, alone or in conjunction with other interventions, might prevent or assist in the management of pelvic organ prolapse, for example by improving the strength of weakened supporting structures.

Mendeley readers

The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Canada 1 <1%
Unknown 121 98%

Demographic breakdown

Readers by professional status Count As %
Unspecified 19 15%
Student > Bachelor 19 15%
Student > Master 16 13%
Student > Ph. D. Student 15 12%
Student > Doctoral Student 11 9%
Other 43 35%
Readers by discipline Count As %
Medicine and Dentistry 61 50%
Unspecified 25 20%
Nursing and Health Professions 14 11%
Engineering 6 5%
Social Sciences 5 4%
Other 12 10%